A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy

Completed

Plain-English translation of NCT04349072 on ClinicalTrials.gov ↗ · Source last updated May 2025 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(21 sites)

United States

Local Institution - 0009, Los Angeles, California

Local Institution - 0011, Stanford, California

Local Institution - 0001, New Haven, Connecticut

Local Institution - 0021, Weston, Florida

Local Institution - 0016, Boston, Massachusetts